U.S. House Committee Chair Calls Out PBM CEOs for False Claims

U.S. House Committee Chair Calls Out PBM CEOs for False Claims

On August 28, House Oversight and Accountability Committee Chairman James Comer (R-Ky.) sent letters to the CEOs of CVS Caremark, Express Scripts, and OptumRx asking that they “correct the record” for false and contradictory statements made during the committee’s July 23 hearing.

Comer pointed out that the three CEOs’ testimony was contrary to the findings in both the FTC’s report from earlier this summer and the committee’s staff report. The executives claimed that their PBMs don’t steer patients to their own pharmacies, that they have opaque contract negotiations and opt-out terms, all of which run counter to bipartisan findings.

Comer also noted that under the law those who are untruthful in committee testimony under oath run the risk of a fine or five years imprisonment. The committee is asking the CEOs to provide their corrections to the record within three weeks.

Read Comer’s individual letters to CVS CaremarkExpress Scripts, and OptumRx here.